Cargando…

Neuroprotective Treatments for Digestive Forms of Chagas Disease in Experimental Models: A Systematic Review

Chagas disease is an anthropozoonosis caused by the protozoan Trypanosoma cruzi and is characterized as a neglected disease. It is currently endemic in 21 countries on the Latin American continent, including Bolivia, Argentina, and Paraguay. Unfortunately, there are no optimally effective treatments...

Descripción completa

Detalles Bibliográficos
Autores principales:	do Carmo Neto, José Rodrigues, Guerra, Rhanoica Oliveira, Rodrigues, Wellington Francisco, da Silva, Marcos Vinicius, Machado, Juliana Reis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527410/ https://www.ncbi.nlm.nih.gov/pubmed/36199427 http://dx.doi.org/10.1155/2022/9397290

Ejemplares similares

Cardiac Chagas Disease: MMPs, TIMPs, Galectins, and TGF-β as Tissue Remodelling Players
por: da Costa, Arthur Wilson Florencio, et al.
Publicado: (2019)

Metabolic and immunological evaluation of patients with indeterminate and cardiac forms of Chagas disease
por: Rocha, Ivonete Helena, et al.
Publicado: (2020)

NOD2 receptor is crucial for protecting against the digestive form of Chagas disease
por: Pereira, Nathalie de Sena, et al.
Publicado: (2020)

Biomakers in Chronic Chagas Cardiomyopathy
por: Rodrigues, Angela Braga, et al.
Publicado: (2022)

Different Infective Forms Trigger Distinct Immune Response in Experimental Chagas Disease
por: Vieira, Paula Melo de Abreu, et al.
Publicado: (2012)

Effects of Meglumine Antimoniate Treatment on Cytokine Production in a Patient with Mucosal Leishmaniasis and Chagas Diseases Co-Infection
por: Rezende-Oliveira, Karine, et al.
Publicado: (2020)

Correlation between intestinal BMP2, IFNγ, and neural death in experimental infection with Trypanosoma cruzi
por: do Carmo Neto, José Rodrigues, et al.
Publicado: (2021)

Interleukin-32γ in the Control of Acute Experimental Chagas Disease
por: Braga, Yarlla L. L., et al.
Publicado: (2022)

Intestinal permeability evaluation in patients with chronic Chagas heart failure
por: Rodrigues, Angela Braga, et al.
Publicado: (2023)

Development of Ag-ZnO/AgO Nanocomposites Effectives for Leishmania braziliensis Treatment
por: Barbosa, Rafaela Miranda, et al.
Publicado: (2022)

Immunopathological Aspects of Experimental Trypanosoma cruzi Reinfections
por: Reis Machado, Juliana, et al.
Publicado: (2014)

Right Ventricular Doppler Echocardiographic Study of Indeterminate Form of Chagas Disease
por: Furtado, Rogério Gomes, et al.
Publicado: (2015)

Biomarkers and Their Possible Functions in the Intestinal Microenvironment of Chagasic Megacolon: An Overview of the (Neuro)inflammatory Process
por: do Carmo Neto, José Rodrigues, et al.
Publicado: (2021)

Differential Expression of Matrix Metalloproteinases 2, 9 and Cytokines by Neutrophils and Monocytes in the Clinical Forms of Chagas Disease
por: Medeiros, Nayara I., et al.
Publicado: (2017)

Treatment of Chagas Cardiomyopathy
por: Botoni, Fernando A., et al.
Publicado: (2013)

Neuroprotective Potential of Non-Digestible Oligosaccharides: An Overview of Experimental Evidence
por: Divyashri, Gangaraju, et al.
Publicado: (2021)

Genetic Susceptibility to Cardiac and Digestive Clinical Forms of Chronic Chagas Disease: Involvement of the CCR5 59029 A/G Polymorphism
por: de Oliveira, Amanda Priscila, et al.
Publicado: (2015)

Triglyceride Form of Docosahexaenoic Acid Mediates Neuroprotection in Experimental Parkinsonism
por: Gómez-Soler, Maricel, et al.
Publicado: (2018)

The Indeterminate Form of Chagas Disease
por: Issa, Victor Sarli
Publicado: (2018)

Home-based exercise program in the indeterminate form of Chagas disease (PEDI-CHAGAS study): A study protocol for a randomized clinical trial
por: Mediano, Mauro F. F., et al.
Publicado: (2023)

Insights from the use of erythropoietin in experimental Chagas disease
por: de Castro Nobre, Ana Carolina, et al.
Publicado: (2022)

Histopathological Correlates of Global and Segmental Left Ventricular Systolic Dysfunction in Experimental Chronic Chagas Cardiomyopathy
por: de Oliveira, Luciano Fonseca Lemos, et al.
Publicado: (2016)

Implantable cardioverter-defibrillator prevents sudden death in patients with Chagas cardiomyopathy in the Brazilian Amazon
por: Couceiro, Katia do Nascimento, et al.
Publicado: (2021)

Benznidazole, itraconazole and their combination in the treatment of acute experimental Chagas disease in dogs
por: Cunha, Eleonora Lima Alves, et al.
Publicado: (2019)

Corrigendum: Home-based exercise program in the indeterminate form of Chagas disease (PEDI-CHAGAS study): a study protocol for a randomized clinical trial
por: Mediano, Mauro F. F., et al.
Publicado: (2023)

Regulatory T Cells Phenotype in Different Clinical Forms of Chagas' Disease
por: de Araújo, Fernanda Fortes, et al.
Publicado: (2011)

Special issue on Chagas disease
por: Coura, José Rodrigues
Publicado: (2015)

Morinda citrifolia (Noni) Fruit Juice Reduces Inflammatory Cytokines Expression and Contributes to the Maintenance of Intestinal Mucosal Integrity in DSS Experimental Colitis
por: Coutinho de Sousa, Beatriz, et al.
Publicado: (2017)

The Colombian Strain of Trypanosoma cruzi Induces a Proinflammatory Profile, Neuronal Death, and Collagen Deposition in the Intestine of C57BL/6 Mice Both during the Acute and Early Chronic Phase
por: do Carmo Neto, José Rodrigues, et al.
Publicado: (2022)

Physical Exercise Promotes a Reduction in Cardiac Fibrosis in the Chronic Indeterminate Form of Experimental Chagas Disease
por: Pedra-Rezende, Yasmin, et al.
Publicado: (2021)

Indeterminate Form of Chagas Disease: Some Immunological Insights
por: Matos, Daniel Mazza, et al.
Publicado: (2022)

Trypanosoma cruzi trans-Sialidase as a Potential Vaccine Target Against Chagas Disease
por: da Costa, Kelli Monteiro, et al.
Publicado: (2021)

Experimental benznidazole treatment of Trypanosoma cruzi II strains isolated from children of the Jequitinhonha Valley, Minas Gerais, Brazil, with Chagas disease
por: de Oliveira-Silva, Jaquelline Carla Valamiel, et al.
Publicado: (2015)

Neuromuscular electrical stimulation in a patient with chronic heart failure due to chagas disease: a case report
por: Bittencourt, Hugo Souza, et al.
Publicado: (2011)

Blood DNA methylation marks discriminate Chagas cardiomyopathy disease clinical forms
por: Brochet, Pauline, et al.
Publicado: (2022)

MICA and KIR: Immunogenetic Factors Influencing Left Ventricular Systolic Dysfunction and Digestive Clinical Form of Chronic Chagas Disease
por: Ayo, Christiane Maria, et al.
Publicado: (2021)

Evidence in Favor of an Alternative Glucocorticoid Synthesis Pathway During Acute Experimental Chagas Disease
por: da Silva Oliveira Barbosa, Esdras, et al.
Publicado: (2020)

Complexity and Controversies over the Cytokine Profiles of T Helper Cell Subpopulations in Tuberculosis
por: da Silva, Marcos Vinicius, et al.
Publicado: (2015)

Plasma Cytokine Expression Is Associated with Cardiac Morbidity in Chagas Disease
por: Sousa, Giovane Rodrigo, et al.
Publicado: (2014)

Disfunção Microvascular Coronariana: Isso Realmente Importa na Doença de Chagas?
por: Nunes, Maria do Carmo Pereira
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_smto80doks1h6hplv0itrkk1gk